GLX351322 is primarily utilized in the field of medicinal chemistry for its potential therapeutic properties. It is being investigated for its role in targeting specific cellular pathways involved in disease progression, particularly in oncology. Researchers are exploring its efficacy in inhibiting enzymes or proteins that are crucial for the survival and proliferation of cancer cells. Additionally, GLX351322 is being studied for its potential application in treating inflammatory disorders, as it may modulate immune responses and reduce inflammation. Its development is focused on creating a compound with high selectivity and minimal side effects, making it a promising candidate for future drug therapies.